Needham reiterates Buy rating on Absci, $11 price target

Needham reiterated their Buy rating on Absci's stock with a price target of $11.00.The price target implies an upside of 2.7% from the Sep 22 close of $10.71.Key takeaways from the analyst noteStrong Product Candidate: Absci's lead product candidate, ABS-201, is an innovative anti-prolactin recepto…